BDX vs TERN · P/E 34, rev $21.84B vs $6.12B cap
Becton Dickinson and Company (BDX) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. TERN currently screens at market cap $6.12B.
Not investment advice. Open the BDX and TERN stock pages for the full models.
Not investment advice.